30
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
"RIF: Oral administration after meals, 6 tablets each time, three times daily (tid), from day 1 to day 14 (d1-14), every 3 weeks (q3w), continuous dosing.~Anlotinib : Oral administration before breakfast, 10 mg each time, once daily (qd), from day 1 to day 14 (d1-14), every 3 weeks (q3w), continuous dosing.~Subjects will continue the study treatment until meeting the protocol-defined discontinuation criteria. The total treatment duration should not exceed 18 months."
Beijing Friendship Hospital
OTHER
Peking University First Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Tianjin People's Hospital
OTHER
The First Affiliated Hospital of Shanxi Medical University
OTHER
Tianchang Yifan Pharmaceutical Co., Ltd.
UNKNOWN
Peking University People's Hospital
OTHER